Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma

Annals of Hematology

Volumn 91, Issue 2, 2012, Pages 291-294

  Yang, Shih Hung ^a   Lin, Long Wei ^a   Fang, Yu Jen ^a   Cheng, Ann Lii ^a,b   Kuo, Sung Hsin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPIRUBICIN; LAMIVUDINE; RITUXIMAB; VINCRISTINE;

ABDOMINAL PAIN; ACUTE HEPATITIS; ADULT; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ERYTHEMA INFECTIOSUM; FEMALE; HEPATITIS B; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE OBSTRUCTION; INTESTINE TUMOR; LARGE CELL LYMPHOMA; LETTER; LEUKOPENIA; LIVER BIOPSY; LIVER FUNCTION; LYMPHOBLAST; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ERYTHEMA INFECTIOSUM; FEMALE; HEPATITIS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; PARVOVIRUS B19, HUMAN;

EID: 84857363748     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1238-8     Document Type: Letter

References (13)

1. S Daum R Ullrich W Heise, et al. 2003 Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin's lymphoma J Clin Oncol 21 2740 2746 12860953 10.1200/JCO.2003.06.026 (Pubitemid 46606320)
2. JW Friedberg RI Fisher 2008 Diffuse large B-cell lymphoma Hematol Oncol Clin North Am 22 941 952 18954744 10.1016/j.hoc.2008.07.002
3. S Aksoy H Harputluoglu S Kilickap, et al. 2007 Rituximab-related viral infections in lymphoma patients Leuk Lymphoma 48 1307 1312 17613758 10.1080/10428190701411441 1:CAS:528:DC%2BD2sXnsVyqs74%3D (Pubitemid 47079357)
4. SH Kuo LI Lin CJ Chang, et al. 2002 Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy J Clin Microbiol 40 3909 3912 12409350 10.1128/JCM.40.11.3909-3912. 2002 (Pubitemid 35285766)
5. AN Langnas RS Markin MS Cattral, et al. 1995 Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia Hepatology 22 1661 1665 7489971 1:STN:280:DyaK28%2FovVyiuw%3D%3D
6. YV Karetnyi PR Beck RS Markin, et al. 1999 Human parvovirus B19 infection in acute fulminant liver failure Arch Virol 144 1713 1724 10542021 10.1007/s007050050699 1:CAS:528:DyaK1MXnsFWhsbo%3D (Pubitemid 29490033)
7. PR Quemelo DM Lima BA da Fonseca, et al. 2007 Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues Rev Inst Med Trop São Paulo 49 103 107 17505669 10.1590/S0036- 46652007000200007 (Pubitemid 46741800)
8. TC Hsu GJ Tsay 2001 Human parvovirus B19 infection in patients with systemic lupus erythematosus Rheumatol (Oxf) 40 152 157 10.1093/rheumatology/40. 2.152 1:STN:280:DC%2BD3MzisValuw%3D%3D
9. C Wang A Heim V Schlaphoff, et al. 2009 Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis J Med Virol 81 2079 2088 19856479 10.1002/jmv.21638 1:CAS:528:DC%2BD1MXhsVyqsbzP
10. JT Hartmann I Meisinger SM Kröber, et al. 2006 Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma Haematologica 91 12 Suppl ECR49 17194655
11. JG Hillingsø IP Jensen L Tom-Petersen 1998 Parvovirus B19 and acute hepatitis in adults Lancet 351 955 956 9734945 (Pubitemid 28138472)
12. SH Yang SH Kuo 2008 Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma Ann Hematol 87 325 327 17932671 10.1007/s00277-007-0396-1 (Pubitemid 351445293)
13. P McLaughlin A Grillo-Lo'pez BK Link, et al. 1998 Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 16 2825 2833 9704735 1:CAS:528:DyaK1cXlsFCgu7c%3D (Pubitemid 28363048)